LY2228820 dimesylate
LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
Product Specifications
CAS Number
862507-23-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
612.737
Molecular Formula
C26H37FN6O6S2
Notes
Research use only, not for human use.
Receptor
P38α
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS524244-01 3 mg
Anti-Horse IgG (H+L), FITC, (Polyclonal) (rabbit IgG)
Sign In for Pricing
View Details MBS524244-02 5x 3 mg
Anti-Horse IgG (H+L), FITC, (Polyclonal) (rabbit IgG)
Sign In for Pricing
View Details 
MBS6202603-01 0.1 mL
Porimin (Keratinocytes-associated Transmembrane Protein 3, KCT-3, Pro-oncosis Receptor Inducing Membrane Injury, Transmembrane Protein 123, TMEM123, KCT3, PSEC0111, UNQ641/PRO1271) (MaxLight 490)
Sign In for Pricing
View Details